[시장보고서]POC(Point of Care) 지질 검사 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 질환 적응증별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

POC(Point of Care) 지질 검사 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 질환 적응증별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Point Of Care Lipid Test Market Size, Share & Trends Analysis Report By Product, By Application, By Disease Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1789954

리서치사 : Grand View Research

발행일 : 2025년 07월

페이지 정보 : 영문 136 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,590,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,034,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,922,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

POC(Point-of-Care) 지질 검사 시장 개요

POC(Point-of-Care) 지질 검사 세계 시장 규모는 2024년에 7억 3,330만 달러로 추정되며 2033년에는 12억 6,833만 달러에 달할 것으로 예상되며, 2025년부터 2033년까지 6.05%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 시장 성장의 원동력은 임상 및 비임상, 특히 심혈관질환의 조기 발견 및 모니터링을 위해 빠르고 쉽게 이용할 수 있는 지질 프로파일링에 대한 수요가 증가하고 있다는 점입니다.

현장 진료 지질 검사는 편의성, 시간 단축, 즉각적인 임상적 의사결정 지원, 1차 진료소, 약국, 지역 의료 프로그램에서의 채택에 기여하고 있습니다.

이상지질혈증 및 생활습관병 유병률 증가와 심혈관계 위험 관리에 대한 인식이 높아지면서 시장 성장세를 견인하고 있습니다. 이러한 검사와 디지털 헬스 플랫폼 및 모바일 진단의 통합은 특히 의료 서비스가 부족한 지역과 농촌 지역에서 분산형 검진 및 예방 의료를 제공할 수 있게 해줍니다.

POC(Point-of-Care) 지질 검사는 의료 전문가가 검체를 검사기관에 보내지 않고 환자가 있는 곳에서 직접 콜레스테롤 및 관련 지질 수치를 측정할 수 있습니다. 이러한 검사는 일반적으로 손가락을 찔러서 채취하는 소량의 혈액 샘플을 사용하며, 휴대용 기기를 통해 신속하게 결과를 제공합니다. 이를 통해 의사는 특히 콜레스테롤 문제를 관리하고 심장병의 위험을 줄이기 위한 치료법에 대해 더 빠른 결정을 내릴 수 있습니다.

POC 지질 검사는 정기 검진, 만성질환 관리, 응급 의료에서 일반적으로 사용됩니다. 특히 검사실 접근이 제한되어 있는 외딴 지역에서 유용하게 사용할 수 있습니다. 기술의 지속적인 개선으로 이러한 검사는 더 작고, 더 정확하고, 더 쉽게 사용할 수 있습니다. 디지털 헬스 시스템과의 연결성이 향상되고 검사 기능이 고도화됨에 따라 POC 지질 검사는 예방의 중요한 부분으로 자리 잡고 있습니다.

기업 분류
전략 매핑
- 신제품 발매
- 파트너십
- 취득
- 협업
- 자금 조달
주요 기업의 시장 점유율 분석(2024년)
기업 히트맵 분석
기업 개요
- Callegari Srl
- Sinocare Inc.
- Abbott Laboratories
- MiCoBio
- Nova Biomedical
- VivaChek Biotech(Hangzhou) Co., Ltd.
- F. Hoffmann-La Roche Ltd.
- Menarini Group
- SD Biosensor, Inc.

KSM

영문 목차

영문목차

Point of Care Lipid Test Market Summary

The global point of care lipid test market size was estimated at USD 733.3 million in 2024 and is projected to reach USD 1,268.33 million by 2033, growing at a CAGR of 6.05% from 2025 to 2033. Market growth is driven by rising demand for rapid and accessible lipid profiling in both clinical and non-clinical settings, especially for early detection and monitoring of cardiovascular conditions.

Point of care lipid testing offers convenience, reduced turnaround time, and immediate clinical decision-making support, contributing to its adoption across primary care centers, pharmacies, and community health programs.

The increasing prevalence of dyslipidemia and lifestyle-related disorders, combined with growing awareness of cardiovascular risk management, supports the market's momentum. Integration of these tests with digital health platforms and mobile diagnostics is further enabling decentralized screening and preventive care delivery, particularly in underserved and rural regions.

Point of care (POC) lipid testing allows healthcare professionals to measure cholesterol and related lipid levels directly at the patient's location, without sending samples to a lab. These tests use small blood samples, usually taken from a finger prick, and provide quick results through portable devices. This helps doctors make faster decisions about treatment, especially for managing cholesterol problems and reducing heart disease risk.

POC lipid tests are commonly used in regular check-ups, chronic disease management, and emergency care. They are especially helpful in remote areas where lab access is limited. Ongoing improvements in technology are making these tests smaller, more accurate, and easier to use. With better connectivity to digital health systems and more advanced testing features, POC lipid testing is becoming an important part of preventive.

Global Point of Care Lipid Test Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global point of care lipid test market report based on product, application, disease indication, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Consumables
Application Outlook (Revenue, USD Million, 2021 - 2033)
Hyperlipidemia
Hypertriglyceridemia
Tangier Disease
Hyperlipoproteinemia
Familial Hypercholesterolemia
Others
Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)
Lipid and Lipoprotein Disorders
Atherosclerosis
Liver and Renal Diseases
Diabetes Mellitus
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Clinics
Research and Diagnostic Laboratories
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Point of Care Lipid Test Market: Methodology and Scope

1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
  - 1.1.1.1. Product Segment
  - 1.1.1.2. Application Segment
  - 1.1.1.3. Disease Indication segment
  - 1.1.1.4. End Use
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
- 1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. Point of Care Lipid Test Market: Executive Summary

2.1. Market Snapshot
2.2. Product and Application Snapshot
2.3. Disease Indication Snapshot
2.4. End Use Snapshot
2.5. Competitive Landscape Snapshot

Chapter 3. Point of Care Lipid Test Market Variables, Trends, & Scope

3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraint Analysis
3.4. Porter's Five Forces Analysis
3.5. PESTLE Analysis
3.6. Pipeline Analysis

Chapter 4. Point of Care Lipid Test Market: Product Estimates & Trend Analysis

4.1. Point of Care Lipid Test Market: Product Movement Analysis
4.2. Instruments
- 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3. Consumables
- 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Point of Care Lipid Test Market: Application Estimates & Trend Analysis

5.1. Point of Care Lipid Test Market: Application Movement Analysis
5.2. Hyperlipidemia
- 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3. Hypertriglyceridemia
- 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Tangier Disease
- 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Hyperlipoproteinemia
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Familial Hypercholesterolemia
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Others
- 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Point of Care Lipid Test Market: Indication Outlook Estimates & Trend Analysis

6.1. Point of Care Lipid Test Market: Technology Movement Analysis
6.2. Lipid and Lipoprotein Disorders
- 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3. Atherosclerosis
- 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Liver and Renal Diseases
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Diabetes Mellitus
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Others
- 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Point of Care Lipid Test Market: End Use Estimates & Trend Analysis

7.1. Point of Care Lipid Test Market: End Use Movement Analysis
7.2. Hospitals
- 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3. Clinics
- 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Research and Diagnostic Laboratories
- 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Others
- 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Point of Care Lipid Test Market: Regional Business Analysis

8.1. Regional Market Snapshot
8.2. North America
- 8.2.1. North America Point of Care Lipid Test Market Estimates And Forecast, 2021 - 2033 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. U.S. Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.2.2.2. Key Country Dynamics
  - 8.2.2.3. Regulatory Framework
  - 8.2.2.4. Reimbursement Scenario
  - 8.2.2.5. Competitive Scenario
- 8.2.3. Canada
  - 8.2.3.1. Canada Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.2.3.2. Key Country Dynamics
  - 8.2.3.3. Regulatory Framework
  - 8.2.3.4. Reimbursement Scenario
  - 8.2.3.5. Competitive Scenario
- 8.2.4. Mexico
  - 8.2.4.1. Mexico Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.2.4.2. Key Country Dynamics
  - 8.2.4.3. Regulatory Framework
  - 8.2.4.4. Reimbursement Scenario
  - 8.2.4.5. Competitive Scenario
8.3. Europe
- 8.3.1. Europe Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
- 8.3.2. UK
  - 8.3.2.1. UK Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.3.2.2. Key Country Dynamics
  - 8.3.2.3. Regulatory Framework
  - 8.3.2.4. Reimbursement Scenario
  - 8.3.2.5. Competitive Scenario
- 8.3.3. Germany
  - 8.3.3.1. Germany Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.3.3.2. Key Country Dynamics
  - 8.3.3.3. Regulatory Framework
  - 8.3.3.4. Reimbursement Scenario
  - 8.3.3.5. Competitive Scenario
- 8.3.4. Spain
  - 8.3.4.1. Spain Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.3.4.2. Key Country Dynamics
  - 8.3.4.3. Regulatory Framework
  - 8.3.4.4. Reimbursement Scenario
  - 8.3.4.5. Competitive Scenario
- 8.3.5. France
  - 8.3.5.1. France Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.3.5.2. Key Country Dynamics
  - 8.3.5.3. Regulatory Framework
  - 8.3.5.4. Reimbursement Scenario
  - 8.3.5.5. Competitive Scenario
- 8.3.6. Italy
  - 8.3.6.1. Italy Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.3.6.2. Key Country Dynamics
  - 8.3.6.3. Regulatory Framework
  - 8.3.6.4. Reimbursement Scenario
  - 8.3.6.5. Competitive Scenario
- 8.3.7. Denmark
  - 8.3.7.1. Denmark Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.3.7.2. Key Country Dynamics
  - 8.3.7.3. Regulatory Framework
  - 8.3.7.4. Reimbursement Scenario
  - 8.3.7.5. Competitive Scenario
- 8.3.8. Sweden
  - 8.3.8.1. Sweden Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.3.8.2. Key Country Dynamics
  - 8.3.8.3. Regulatory Framework
  - 8.3.8.4. Reimbursement Scenario
  - 8.3.8.5. Competitive Scenario
- 8.3.9. Norway
  - 8.3.9.1. Norway Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.3.9.2. Key Country Dynamics
  - 8.3.9.3. Regulatory Framework
  - 8.3.9.4. Reimbursement Scenario
  - 8.3.9.5. Competitive Scenario
8.4. Asia Pacific
- 8.4.1. Asia-Pacific Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
- 8.4.2. Japan
  - 8.4.2.1. Japan Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.4.2.2. Key Country Dynamics
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. Reimbursement Scenario
  - 8.4.2.5. Competitive Scenario
- 8.4.3. China
  - 8.4.3.1. China Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.4.3.2. Key Country Dynamics
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Reimbursement Scenario
  - 8.4.3.5. Competitive Scenario
- 8.4.4. India
  - 8.4.4.1. India Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.4.4.2. Key Country Dynamics
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. Reimbursement Scenario
  - 8.4.4.5. Competitive Scenario
- 8.4.5. South Korea
  - 8.4.5.1. South Korea Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.4.5.2. Key Country Dynamics
  - 8.4.5.3. Regulatory Framework
  - 8.4.5.4. Reimbursement Scenario
  - 8.4.5.5. Competitive Scenario
- 8.4.6. Thailand
  - 8.4.6.1. Thailand Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.4.6.2. Key Country Dynamics
  - 8.4.6.3. Regulatory Framework
  - 8.4.6.4. Reimbursement Scenario
  - 8.4.6.5. Competitive Scenario
- 8.4.7. Australia
  - 8.4.7.1. Australia Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.4.7.2. Key Country Dynamics
  - 8.4.7.3. Regulatory Framework
  - 8.4.7.4. Reimbursement Scenario
  - 8.4.7.5. Competitive Scenario
8.5. Latin America
- 8.5.1. Latin America Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Brazil Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.5.2.2. Key Country Dynamics
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Reimbursement Scenario
  - 8.5.2.5. Competitive Scenario
- 8.5.3. Argentina
  - 8.5.3.1. Argentina Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.5.3.2. Key Country Dynamics
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. Reimbursement Scenario
  - 8.5.3.5. Competitive Scenario
8.6. MEA
- 8.6.1. MEA Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
- 8.6.2. South Africa
  - 8.6.2.1. South Africa Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.6.2.2. Key Country Dynamics
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Reimbursement Scenario
  - 8.6.2.5. Competitive Scenario
- 8.6.3. Saudi Arabia
  - 8.6.3.1. Saudi Arabia Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.6.3.2. Key Country Dynamics
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. Reimbursement Scenario
  - 8.6.3.5. Competitive Scenario
- 8.6.4. UAE
  - 8.6.4.1. UAE Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.6.4.2. Key Country Dynamics
  - 8.6.4.3. Regulatory Framework
  - 8.6.4.4. Reimbursement Scenario
  - 8.6.4.5. Competitive Scenario
- 8.6.5. Kuwait
  - 8.6.5.1. Kuwait Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  - 8.6.5.2. Key Country Dynamics
  - 8.6.5.3. Regulatory Framework
  - 8.6.5.4. Reimbursement Scenario
  - 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

9.1. Company Categorization
9.2. Strategy Mapping
- 9.2.1. New Product Launch
- 9.2.2. Partnerships
- 9.2.3. Acquisition
- 9.2.4. Collaboration
- 9.2.5. Funding
9.3. Key Company Market Share Analysis, 2024
9.4. Company Heat Map Analysis
9.5. Company Profiles
- 9.5.1. Callegari Srl
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Financial Performance
  - 9.5.1.3. Product Benchmarking
  - 9.5.1.4. Strategic Initiatives
- 9.5.2. Sinocare Inc.
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Financial Performance
  - 9.5.2.3. Product Benchmarking
  - 9.5.2.4. Strategic Initiatives
- 9.5.3. Abbott Laboratories
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Financial Performance
  - 9.5.3.3. Product Benchmarking
  - 9.5.3.4. Strategic Initiatives
- 9.5.4. MiCoBio
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Financial Performance
  - 9.5.4.3. Product Benchmarking
  - 9.5.4.4. Strategic Initiatives
- 9.5.5. Nova Biomedical
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Financial Performance
  - 9.5.5.3. Product Benchmarking
  - 9.5.5.4. Strategic Initiatives
- 9.5.6. VivaChek Biotech (Hangzhou) Co., Ltd.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Financial Performance
  - 9.5.6.3. Product Benchmarking
  - 9.5.6.4. Strategic Initiatives
- 9.5.7. F. Hoffmann-La Roche Ltd.
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Financial Performance
  - 9.5.7.3. Product Benchmarking
  - 9.5.7.4. Strategic Initiatives
- 9.5.8. Menarini Group
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Financial Performance
  - 9.5.8.3. Product Benchmarking
  - 9.5.8.4. Strategic Initiatives
- 9.5.9. SD Biosensor, Inc.
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Financial Performance
  - 9.5.9.3. Product Benchmarking
  - 9.5.9.4. Strategic Initiatives

한글목차

목차

제1장 POC(Point of Care) 지질 검사 시장 : 조사 방법과 범위

제2장 POC(Point of Care) 지질 검사 시장 : 주요 요약

제3장 POC(Point of Care) 지질 검사 시장 변수, 동향, 범위

제4장 POC(Point of Care) 지질 검사 시장 : 제품별 추정·동향 분석

제5장 POC(Point of Care) 지질 검사 시장 : 용도별 추정·동향 분석

제6장 POC(Point of Care) 지질 검사 시장 : 질환 적응증별 추정·동향 분석

제7장 POC(Point of Care) 지질 검사 시장 : 최종 용도별 추정·동향 분석

제8장 POC(Point of Care) 지질 검사 시장 : 지역별 비즈니스 분석

제9장 경쟁 구도